DarioHealth Stock Price. Everything You Need To Know About The DarioHealth Stock!
DarioHealth Corp. is a digital therapeutics company based in New York City that specializes in the research, development, and sale of pharmaceutical products. The company went public on March 8th, 2013 and currently employs 241 full-time employees.
DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The company offers digital therapeutics solutions for multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal and behavioral health.
DarioHealth’s products include the Dario Blood Glucose Monitoring Starter Kit, a pocket-sized smartphone blood glucose meter that measures sugar levels, and the Dario Blood Pressure Monitoring System, a blood pressure monitoring system that stores all user readings in the Dario App. The company’s Dario mobile application and the Dario Blood sugar (glucose) meter enable users to track and check blood sugar (glucose) levels in real-time.
By staying up-to-date with DarioHealth’s stock price today and market cap, you can make more informed decisions about investing in the digital therapeutics industry. And, if you or someone you know requires digital therapeutics solutions for chronic conditions, DarioHealth’s offerings might be worth exploring. The company’s innovative products and solutions represent a promising approach to improving health outcomes for patients.
DarioHealth Stock Price. Everything You Need To Know About The DarioHealth Stock! performance
- Employees 241
- Company HQ New York City
- Website http://mydario.com
- DRIO Asset Type Common Stock
- DRIO Market Capitalization 43.9M
- Earnings Per Share -1.93
- Dividends Per Share None
- Dividend Date 2019-11-18
- Quarterly Earnings Growth 0
Are you interested in investing in international stocks but unsure where to start? Look no further than DarioHealth, a revolutionary digital health solution company. With its cutting-edge technologies and innovative approach to healthcare, DarioHealth is a stock that presents immense potential for investors. But how can you, as a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, invest in this exciting opportunity? Firstly, it is essential to have a reliable investment platform like Zorion to access international stocks. Zorion provides users from these countries with a seamless and secure investment experience, allowing you to invest in real US stocks and Pre-IPO companies like DarioHealth. Additionally, Zorion offers investment insights and recommendations tailored specifically to retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Once you have chosen the right platform, you need to understand the fundamentals of investing in DarioHealth. It’s crucial to conduct thorough research on the company’s financials, market position, and growth potential. Zorion can provide you with the necessary resources and educational materials to enhance your investment knowledge and help you make informed decisions. Furthermore, keep a close eye on the latest news and developments surrounding DarioHealth. Stay informed about the company’s innovations, partnerships, and growth strategies. This information can influence your investment decisions and enable you to make strategic moves. When investing in DarioHealth or any other international stock, remember to diversify your portfolio. While investing in a promising company like DarioHealth can be exciting, it’s essential to spread your investments across different sectors and countries to manage risk effectively. Investing in international stocks can be a rewarding experience, and with the right tools and resources, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can seize the opportunity to invest in DarioHealth. Partner with Zorion, gain access to the world of international stocks, and start your investment journey today.
